Nature Communications (Oct 2022)

Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern

  • Danique M. H. van Rijswijck,
  • Albert Bondt,
  • Max Hoek,
  • Karlijn van der Straten,
  • Tom G. Caniels,
  • Meliawati Poniman,
  • Dirk Eggink,
  • Chantal Reusken,
  • Godelieve J. de Bree,
  • Rogier W. Sanders,
  • Marit J. van Gils,
  • Albert J. R. Heck

DOI
https://doi.org/10.1038/s41467-022-33899-1
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 10

Abstract

Read online

Profiling antibody repertoires using proteomic approaches may provide a way of screening for antibody cross-reactivity against SARS-CoV-2 variants. Here the authors use a IgG1 specific cleavage method to analyse the IgG1 repertoire within recovered patients and relate this to antibody binding and neutralisation.